ACUTE PRESYNAPTIC INHIBITION BY DOXORUBICIN OF NEGATIVE CHRONOTROPIC AND INOTROPIC RESPONSES TO PARASYMPATHETIC NERVE-STIMULATION IN ISOLATED, BLOOD-PERFUSED DOG ATRIUM

Citation
Y. Hoyano et al., ACUTE PRESYNAPTIC INHIBITION BY DOXORUBICIN OF NEGATIVE CHRONOTROPIC AND INOTROPIC RESPONSES TO PARASYMPATHETIC NERVE-STIMULATION IN ISOLATED, BLOOD-PERFUSED DOG ATRIUM, Journal of cardiovascular pharmacology, 27(1), 1996, pp. 37-41
Citations number
38
Categorie Soggetti
Cardiac & Cardiovascular System","Respiratory System","Pharmacology & Pharmacy
ISSN journal
01602446
Volume
27
Issue
1
Year of publication
1996
Pages
37 - 41
Database
ISI
SICI code
0160-2446(1996)27:1<37:APIBDO>2.0.ZU;2-X
Abstract
The clinical use of doxorubicin, an anthracycline antineoplastic agent , is limited by its cardiotoxicity. Although several previous reports have shown neurotoxic effects of doxorubicin, there is little informat ion about the acute effects of doxorubicin on the autonomic nerve func tions in the heart. Accordingly, to evaluate the effects of doxorubici n on the cardiac responses to autonomic nerve activation, we studied t he effects of doxorubicin on the negative chrono- and inotropic respon ses to intracardiac parasympathetic nerve stimulation and acetylcholin e (ACh), and the positive chrono- and inotropic responses to norepinep hrine (NE) in the isolated, blood-perfused dog atrium. Doxorubicin (0. 01-3 mu mol), injected into the sinus node artery of the isolated atri um, induced negative inotropic effects dose dependently and weak negat ive chronotropic effects. Doxorubicin inhibited the negative chrono- a nd inotropic responses to parasympathetic nerve stimulation dose depen dently. However, doxorubicin affected neither the negative chrono- and inotropic responses to ACh nor the positive chrono- and inotropic res ponses to NE. These results indicate that doxorubicin interacts with n either muscarinic receptors nor P-adrenoceptors and suggest that doxor ubicin inhibits the negative cardiac responses to parasympathetic nerv e activation due to the inhibition of ACh release from nerve varicosit ies in the heart.